Biotech
CHESTERTOWN, MD: Launches the Commercialization Phase of sugardown(R) in North America ...
PALATINE, IL: PALATINE, IL -- (Marketwired) -- 09/29/14 -- Acura Pharmaceuticals Inc. (NASDAQ: ACUR) announced today preliminary results from three clinical studies for its abuse deterrent AVERSION® hydrocodone b ...
DUBLIN, IRELAND: Elizabeth M. Higashi, CFA Appointed Vice President, Investor Relations ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 09/26/14 -- Immunovaccine Inc. ("Immunovaccine" or "IMV" or "the Company") (TSX VENTURE: IMV), a clinical stage vaccine and imm ...
WINNIPEG, MANITOBA: WINNIPEG, MANITOBA -- (Marketwired) -- 09/25/14 -- Miraculins Inc. (TSX VENTURE: MOM) ("Miraculins" or the "Company"), a medical diagnostic company focused on acquiring, developi ...
NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 09/24/14 -- Kadmon Corporation, LLC announces today that Harlan W. Waksal, M.D., has joined the Company as its President and Chief Executive Officer after serving as ...
NEEDHAM, MA: Provider of Online and Onsite Bioinformatics Training to Join Cambridge Healthtech Institute as Division of Bio-IT World ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 09/24/14 -- announced today that it has updated coverage on (OTCBB: SNGX), based in Princeton, New Jersey, and revised its twelve-month price target higher fro ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/24/14 -- Calyx Bio-Ventures Inc. (TSX VENTURE: CYX) ("Calyx") is pleased to announce it has entered into definitive agreements to acquire ...
HUDSON, NY: HUDSON, NY -- (Marketwired) -- 09/23/14 -- Taconic announced today that it has changed the legal name of the company from Taconic Farms, Inc. to Taconic Biosciences, Inc. The change in Taconic's ...
DUBLIN, IRELAND: ACTIMMUNE(R) (Interferon gamma-1b) Phase 2 Results in Friedreich's Ataxia to Be Presented ...
SEATTLE, WA: Investor Call Scheduled for September 24, 2014 at 9:00 am EDT ...
PHILADELPHIA, PA: Inviting Heads, VPs, Directors, Managers, and Specialists of Labeling and Regulatory Affairs From Leading Pharmaceutical and Biotech Companies to Discuss Best Practices for Generic Label Documentation ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 09/23/14 -- (OTCBB: TTNP) today announced that patient enrollment in the Phase 3 study of Probuphine®, the company's investigational subdermal impla ...
MANCHESTER, NH: MANCHESTER, NH -- (Marketwired) -- 09/23/14 -- Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), a developer of complex carbohydrate therapeutics t ...
DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 09/22/14 -- Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company with a portfolio of products in arthritis, inflammation and orphan diseases, t ...
MANCHESTER, NH: 360 Patients to Be Enrolled in Phase III Study at 10 Sites in Four Countries; BTI-320, a Non-Systemic Chewable Tablet, Represents a New Generation of Alpha Glycosidase Inhibitors ...
BERKELEY, CA: BERKELEY, CA -- (Marketwired) -- 09/22/14 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced completion of planned enrollment in the ongoing phase 3 clinical trial of HEPLISAV-B, its ...
